cancer antigen 125 (CA-125) antibody and antigen (Recombinant protein)

Diagnostic cancer antigen 125 (CA-125) antibodies (anti-cancer antigen 125, anti-CA-125) and antigens (recombinant cancer antigen 125 (CA-125) protein) for Cancer CA-125 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Cancer diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-CA-125-Ag01 Recombinant human CA-125 Protein $3090.00
GMP-h-CA-125-Ab01 Anti-human CA-125 mouse monoclonal antibody (mAb) $1953.00
GMP-h-CA-125-Ab02 Anti-human CA-125 mouse monoclonal antibody (mAb) $1953.00
GMP-h-CA-125-Ab03 Anti-human CA-125 human monoclonal antibody (mAb) $1953.00
GMP-h-CA-125-Ab04 Anti-human CA-125 human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Pruducts GMP-h-CA-125-Ag01
Product Name Recombinant human CA-125 Protein
Target/Biomarker cancer antigen 125 (CA-125)
Alias of Target/Biomarker #N/A
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation cancer antigen 125 (CA-125) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation
Products description Recombinant Human cancer antigen 125 (CA-125) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts GMP-h-CA-125-Ab01,GMP-h-CA-125-Ab02
Product Name Anti-human CA-125 mouse monoclonal antibody (mAb)
Target/Biomarker cancer antigen 125 (CA-125)
Alias of Target/Biomarker #N/A
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human cancer antigen 125 (CA-125) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation.
Tag mFc
Products description Anti-human CA-125 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. of Pruducts GMP-h-CA-125-Ab03,GMP-h-CA-125-Ab04
Product Name Anti-human CA-125 human monoclonal antibody (mAb)
Target/Biomarker cancer antigen 125 (CA-125)
Alias of Target/Biomarker #N/A
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Human cancer antigen 125 (CA-125) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation.
Tag hFc
Products description Anti-human CA-125 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in symptomatic women presenting to primary care. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood. A CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease. A CA 125 test isn't accurate enough to use for ovarian cancer screening in general because many noncancerous conditions can increase the CA 125 level. Many different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment